Sight-saving specialist Newmedica has officially opened a multimillion-pound clinic for the people of Hampshire.
Both the American Academy of Ophthalmology (AAO) and the European Glaucoma Society (EGS) have updated their preferred practice regimens to recognize or recommend SLT as an initial intervention for glaucoma and the NICE UK are now guiding doctors to use SLT before drops.
Researchers, funded by Glaucoma UK in partnership with The Royal College of Ophthalmologists, are investigating the potential for personalised glaucoma care by mapping clinical trial data and real-word outcomes to individuals.
Eye clinic, Midland Eye, announces the success of its first sight-saving Preserflo Microshunt glaucoma procedure.
Four world-leading experts, including Hari Jayaram and Gus Gazzard from Moorfields, have combined their knowledge with the findings from over 150 peer-reviewed study publications to produce a landmark paper published in the Lancet.
Ciliatech presents preliminary one-year study results on treating open- and narrow-angle glaucoma with CID at Ophthalmology Futures Symposium.
Glaucoma UK’s campaign for National Eye Health Week 2023, which will run from 18-24 September, focuses on delivering essential bitesize information about glaucoma that can be read or viewed in under one minute.
Glaucoma UK is marking Glaucoma Awareness Week 2023, which will run from 26 June to 2 July 2023.
Dr Sancy Low, Consultant Ophthalmic Surgeon at Guy’s and St Thomas’ NHS Foundation Trust, wins the Glaucoma UK ‘Excellence in Glaucoma Care Award 2023’.
Glaucoma UK announces the Open Call Research Award 2023, offering up to £50,000 in funding for glaucoma-related research.
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.
Glaucoma UK, the Muslim Council of Britain (MCB), and the British Islamic Medical Association (BIMA) are encouraging Muslims with glaucoma to continue using their medication as prescribed during the holy month to prevent irreversible sight loss.